The evaluation through the three-year follow-up (2014–2016) demonstrated statistically significant higher total costs in biological compared to conventional therapy, despite a decreasing trend in the total expenses in both groups over the years.
← all excerpts
The Cost of Inflammatory Bowel Disease Management Matches with Clinical Course: A Single Outpatient Centre Analysis.
1
—
—